Teligent

Pharmaceutics International Inc. (Pii), a Jabil company, is a contract development and manufacturing organization (CDMO) with over 30 years of experience in sophisticated drug product applications. They specialize in aseptic filling, lyophilization, oral solid dose manufacturing, and offering vital formulation development support, driving effective solutions for complex and highly potent drug formulations. Pii is committed to being a flexible and transparent partner, ensuring quality and compliance throughout every phase of drug development. With a strong emphasis on customer needs, they facilitate seamless transitions from clinical trials to commercial success without the need to switch CDMO providers. Generated from the website

Medical Marketing Inc., a family-owned and operated business since 1976, is recognized as a leading specialty distributor of medical supplies and equipment in Maryland, DC, and Virginia. In 1992, the company joined a national network of specialty distributors, enabling them to offer a wide range of innovative and cost-effective medical products to their customers. Focused on providing quality medical supplies, Medical Marketing Inc. prides itself on its long-standing reputation and commitment to service within the healthcare community. Their extensive product offerings cater to various needs, ensuring clients receive both reliability and expertise. Generated from the website

Pharmaceutics International Inc. (Pii) is a contract development and manufacturing organization (CDMO) based in Hunt Valley, MD, specializing in early-stage clinical and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing. With over 30 years of experience, the company is committed to providing flexible, high-quality solutions for complex drug formulations, ensuring timely project delivery and effective solutions. Recently acquired by Jabil Inc., Pii combines industry-leading automation and manufacturing excellence to support a wide range of drug products, including highly potent APIs, prefilled syringes, and oral doses. Their extensive capabilities, backed by a dedicated team of over 300 scientists, ensure a seamless transition from clinical trials to commercial success. Generated from the website